Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
NCT05204017 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-04-13
Summary
CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.
Conditions
- Amyotrophic Lateral Sclerosis
- Primary Lateral Sclerosis
- Progressive Muscular Atrophy
- Frontotemporal Degeneration
Sponsors & Collaborators
- collaborator OTHER
-
Laval University
collaborator OTHER -
University of Toronto
collaborator OTHER -
Simon Fraser University
collaborator OTHER -
University of Alberta
lead OTHER
Principal Investigators
-
Sanjay Kalra, MD · University of Alberta
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-12
- Primary Completion
- 2031-12-31
- Completion
- 2031-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
NCT00677768 ·Status: COMPLETED
-
PREVENT ALL ALS Study
NCT06581861 ·Status: RECRUITING
-
Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project
NCT06820008 ·Status: RECRUITING
-
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
NCT06771414 ·Status: NOT_YET_RECRUITING
-
Amyotrophic Lateral Sclerosis (ALS) Families Project
NCT03865420 ·Status: RECRUITING
-
Genomic Translation for Amyotrophic Lateral Sclerosis Care
NCT02795897 ·Status: COMPLETED
-
Identification of Early Markers for ALS
NCT07213440 ·Status: RECRUITING ·Phase: NA
-
Understanding Clinical Phenotype and Collecting Biomarker Samples in C9ORF72 ALS
NCT02686268 ·Status: COMPLETED
-
Staging System in Amyotrophic Lateral Sclerosis
NCT04858555 ·Status: UNKNOWN
-
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
NCT02000713 ·Status: TERMINATED ·Phase: NA
-
Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy
NCT03664206 ·Status: WITHDRAWN
-
Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids
NCT07260981 ·Status: COMPLETED
-
Neurofilament Assay for the Diagnosis of ALS
NCT05077696 ·Status: UNKNOWN
-
Evaluation of Metabolomic Analysis in Early Diagnosis of ALS
NCT01962311 ·Status: COMPLETED ·Phase: NA
-
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
NCT06083584 ·Status: RECRUITING
-
Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
NCT00302198 ·Status: COMPLETED
-
New Magnetic Resonance Imaging Biomarkers in Amyotrophic Lateral Sclerosis
NCT04691011 ·Status: COMPLETED ·Phase: NA
-
Modeling Amyotrophic Lateral Sclerosis With Fibroblasts
NCT06450691 ·Status: RECRUITING ·Phase: NA
-
A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
NCT01495390 ·Status: COMPLETED
-
Systems Biology of Amyotrophic Lateral Sclerosis (ALS)
NCT07007390 ·Status: NOT_YET_RECRUITING
-
A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects
NCT03519880 ·Status: TERMINATED ·Phase: NA
-
Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)
NCT01950910 ·Status: TERMINATED
-
ASSESS ALL ALS Study
NCT06578195 ·Status: RECRUITING
-
EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)
NCT00718458 ·Status: COMPLETED
-
MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
NCT02410239 ·Status: WITHDRAWN ·Phase: PHASE1